Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "High-density Multiplexed Diagnostic Assays - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
The publisher brings years of research experience to the 6th edition of this report. The 175-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global High-density Multiplexed Diagnostic Assays Market to Reach $3.2 Billion by 2027
Amid the COVID-19 crisis, the global market for High-density Multiplexed Diagnostic Assays estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 14.4% over the period 2020-2027.
High-Density Multiplexed Diagnostic Assays (500-10,000 plex), one of the segments analyzed in the report, is projected to record 14.1% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Very High-Density Multiplexed Diagnostic Assays (>10,000 plex) segment is readjusted to a revised 14.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $363.6 Million, While China is Forecast to Grow at 13.9% CAGR
The High-density Multiplexed Diagnostic Assays market in the U.S. is estimated at US$363.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$551.1 Million by the year 2027 trailing a CAGR of 13.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 12.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.
Competitors identified in this market include, among others:
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Erba Diagnostics, Inc.
F. Hoffmann-La Roche AG
Gold Standard Diagnostics Corporation
Randox Laboratories Ltd.
Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
High-density Multiplexed Diagnostic Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Total Companies Profiled: 46
For more information about this report visit https://www.researchandmarkets.com/r/8r2w4p
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900